Literature DB >> 20011448

Laparoscopy for rectal cancer: the need for randomized trials.

Thomas E Read1, Peter W Marcello.   

Abstract

The adoption of laparoscopic proctectomy for rectal cancer has been relatively slow, primarily because of the technical difficulty of the procedure. The wide surgeon-to-surgeon variability in disease-free survival and local pelvic recurrence noted after open proctectomy is probably due to differences in surgical technique, and these differences are likely to be magnified when the additional challenge of laparoscopy is added to the procedure. At present, oncologic and functional outcomes data are limited. Although the adoption of laparoscopic techniques to perform curative proctectomy is likely to expand as technical challenges are overcome and experience and training improve, the results of prospective multicenter trials are necessary to ensure that the procedures provide an oncologic and functional outcome equivalent to that of conventional surgery.

Entities:  

Keywords:  Laparoscopy; proctectomy; randomized trials; rectal cancer

Year:  2006        PMID: 20011448      PMCID: PMC2789500          DOI: 10.1055/s-2006-939526

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  46 in total

1.  Work loads and practice patterns of general surgeons in the United States, 1995-1997: a report from the American Board of Surgery.

Authors:  W P Ritchie; R S Rhodes; T W Biester
Journal:  Ann Surg       Date:  1999-10       Impact factor: 12.969

2.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

3.  The Surgical Pathology of Rectal Cancer: President's Address.

Authors:  C E Dukes
Journal:  Proc R Soc Med       Date:  1944-02

4.  Prospective evaluation of laparoscopic surgery for rectosigmoidal and rectal carcinoma.

Authors:  Seiichiro Yamamoto; Masahiko Watanabe; Hirotoshi Hasegawa; Masaki Kitajima
Journal:  Dis Colon Rectum       Date:  2002-12       Impact factor: 4.585

5.  Surgeon-related factors and outcome in rectal cancer.

Authors:  G A Porter; C L Soskolne; W W Yakimets; S C Newman
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

6.  Hybrid laparoscopic flexure takedown and open procedure for rectal resection is associated with significantly shorter length of stay than equivalent open resection.

Authors:  S Vithiananthan; Z Cooper; K Betten; G S Stapleton; J Carter; E H Huang; R L Whelan
Journal:  Dis Colon Rectum       Date:  2001-07       Impact factor: 4.585

7.  Prospective comparison of laparoscopic vs. open resections for colorectal adenocarcinoma over a ten-year period.

Authors:  Sanjiv K Patankar; Sergio W Larach; Andrea Ferrara; Paul R Williamson; Joseph T Gallagher; Samuel DeJesus; Shekar Narayanan
Journal:  Dis Colon Rectum       Date:  2003-05       Impact factor: 4.585

8.  Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997.

Authors:  R J Heald; B J Moran; R D Ryall; R Sexton; J K MacFarlane
Journal:  Arch Surg       Date:  1998-08

9.  Surgeon specialty is associated with outcome in rectal cancer treatment.

Authors:  Thomas E Read; Robert J Myerson; James W Fleshman; Robert D Fry; Elisa H Birnbaum; Bruce J Walz; Ira J Kodner
Journal:  Dis Colon Rectum       Date:  2002-07       Impact factor: 4.585

10.  Outcome of laparoscopic surgery for rectal cancer in 101 patients.

Authors:  Matthias Anthuber; Alois Fuerst; Florian Elser; Rita Berger; Karl-Walter Jauch
Journal:  Dis Colon Rectum       Date:  2003-08       Impact factor: 4.585

View more
  1 in total

1.  The variations of the middle colic vein tributaries: depiction by three-dimensional CT angiography.

Authors:  Yumi Maki; Masaru Mizutani; Mamoru Morimoto; Tatsuya Kawai; Motoo Nakagawa; Yoshiyuki Ozawa; Mitsuru Takeuchi; Hiroyuki Maki; Kenichiro Kurosaka; Yuta Shibamoto
Journal:  Br J Radiol       Date:  2016-04-25       Impact factor: 3.039

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.